Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.9825
+0.0225 (2.34%)
At close: Dec 16, 2025, 4:00 PM EST
0.9406
-0.0419 (-4.26%)
After-hours: Dec 16, 2025, 7:56 PM EST
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $5.82 million as of December 16, 2025. Its market cap has increased by 79.60% in one year.
Market Cap
5.82M
Enterprise Value
-7.03M
1-Year Change
79.60%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $5.82M, a decrease of -93.57%. That is a compound annual growth rate of -41.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 5.69M | 47.63% |
| Dec 31, 2024 | 3.85M | 22.18% |
| Dec 29, 2023 | 3.15M | -29.38% |
| Dec 30, 2022 | 4.46M | -93.27% |
| Dec 31, 2021 | 66.32M | -28.84% |
| Dec 31, 2020 | 93.20M | 2.97% |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |